Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

Gilbert, PB; Excler, JL; Tomaras, GD; Carpp, LN; Haynes, BF; Liao, HX; Montefiori, DC; Rerks-Ngarm, S; Pitisuttithum, P; Nitayaphan, S; Kaewkungwal, J; Kijak, GH; Tovanabutra, S; Francis, DP; Lee, C; Sinangil, F; Berman, PW; Premsri, N; Kunasol, P; O

Excler, JL (reprint author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Excler, JL (reprint author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Excler, JL (reprint author), Int Vaccine Initiat, Seoul, S

PLOS ONE, 2017; 12 (5):

Abstract

Background In the HIV-1 vaccine trial RV144, ALVAC-HIV prime with an AIDSVAX (R) B/E boost reduced HIV-1 acquisition by 31% at 42 months post first va......

Full Text Link